Experiences, learnings and perspectives in the regulation of agricultural biotechnology: the view from Argentina.

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-06-06 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1600642
Dalia M Lewi, Perla Godoy, Facundo Simeone
{"title":"Experiences, learnings and perspectives in the regulation of agricultural biotechnology: the view from Argentina.","authors":"Dalia M Lewi, Perla Godoy, Facundo Simeone","doi":"10.3389/fbioe.2025.1600642","DOIUrl":null,"url":null,"abstract":"<p><p>Argentina has established itself as global leader in setting enabling regulations for agricultural biotechnology. Between 2020 and 2023 the responsible administration strengthened this position through the adoption of innovative regulations for New Breeding Techniques and fostering broad international collaboration. The experience accumulated during this period serves to illustrate best practices, current shortcomings, anticipate future challenges, and point to the solutions that the sector will need in the next few years.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1600642"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1600642","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Argentina has established itself as global leader in setting enabling regulations for agricultural biotechnology. Between 2020 and 2023 the responsible administration strengthened this position through the adoption of innovative regulations for New Breeding Techniques and fostering broad international collaboration. The experience accumulated during this period serves to illustrate best practices, current shortcomings, anticipate future challenges, and point to the solutions that the sector will need in the next few years.

农业生物技术管理的经验、教训和观点:来自阿根廷的观点。
阿根廷在为农业生物技术制定有利法规方面已经确立了自己的全球领导地位。在2020年至2023年期间,负责任的行政部门通过采用创新的新育种技术法规和促进广泛的国际合作,加强了这一地位。在此期间积累的经验有助于说明最佳做法,当前的缺点,预测未来的挑战,并指出该行业在未来几年内需要的解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信